arrow
返回
D

David A. Potter

University of Kansas

30H指数
181论文数
3.4K被引数
收录论文 55
发表时间
Endothelial dysfunction in breast cancer survivors on aromatase inhibitors: changes over time
err2024-05-01
err0
errOAAI
errShaaban, Adnan; Petersen, Ashley; Beckwith, Heather; Florea, Natalia; Potter, David A.; Yee, Douglas; Vogel, Rachel I.; Duprez, Daniel; Blaes, Anne H.
err分享
err收藏
Mechanisms of endocrine resistance to letrozole, fulvestrant, and palbociclib are associated with increased sensitivity to hexyl-cuban-1-yl biguanide inhibitors of CYP3A4 mediated epoxyeicosatrienoic acid biosynthesis
err2024-04-05
err0
PREAI
errGuo, Zhijun; Lei, Jianxun; Makovec, Allison; Jayaraman, Swaathi; Hawse, John R.; Lange, Carol; Ambrose, Elizabeth; Georg, Gunda I.; D'Assoro, Tony; Matthew, Goetz P.; Potter, David A.
err分享
err收藏
Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial
err2024-01-12
err1
errOAAI
errWang, Haiyun; Yee, Douglas; Potter, David; Jewett, Patricia; Yau, Christina; Beckwith, Heather; Watson, Allison; O'Grady, Nicholas; Wilson, Amy; Brain, Susie; Pohlmann, Paula; Blaes, Anne
err分享
err收藏
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery在适应性随机I-SPY2试验中,以Trebananib和紫杉醇为基础的新辅助化疗治疗II/III期乳腺癌的疗效和生物标志物发现
err2023-12-18
err2
PREAI
errAlbain, Kathy S.; Yau, Christina; Petricoin, Emanuel F.; Wolf, Denise M.; Lang, Julie E.; Chien, A. Jo; Haddad, Tufia; Forero-Torres, Andres; Wallace, Anne M.; Kaplan, Henry; Pusztai, Lajos; Euhus, David; Nanda, Rita; Elias, Anthony D.; Clark, Amy S.; Godellas, Constantine; Boughey, Judy C.; Isaacs, Claudine; Tripathy, Debu; Lu, Janice; Yung, Rachel L.; Gallagher, Rosa I.; Wulfkuhle, Julia D.; Brown-Swigart, Lamorna; Krings, Gregor; Chen, Yunn Yi; Potter, David A.; Stringer-Reasor, Erica; Blair, Sarah; Asare, Smita M.; Wilson, Amy; Hirst, Gillian L.; Singhrao, Ruby; Buxton, Meredith; Clennell, Julia L.; Sanil, Ashish; Berry, Scott; Asare, Adam L.; Matthews, Jeffrey B.; Demichele, Angela M.; Hylton, Nola M.; Melisko, Michelle; Perlmutter, Jane; Rugo, Hope S.; Symmans, W. Fraser; van't Veer, Laura J.; Yee, Douglas; Berry, Donald A.; Esserman, Laura J.
err分享
err收藏
Hexyl-(cuban-1-yl-methyl)-biguanide (HCB) suppresses N-glycosylation of immune checkpoint proteins B7-H3 and B7-H4, reverses tumor hypoxia, decreases intratumoral regulatory T cells, and increases intratumoral CD8+T cells in the ovarian dependent ER+HER2-SSM2ucd mammary cancer allograft model
err2023-04-14
err1
PREAI
errGuo, Zhijun; Lei, Jianxun; Venkatesh, Hrishi; Owen, David; Bass, Adam; Cannon, Christine; McCarra, Joshua; Koniar, Brenda; Flory, Craig; Norris, Beverly; Schumacher, Robert J.; Jayaraman, Swaathi; Hawse, John; Antonarakis, Emmanuel S.; Petricoin, Emanuel F.; Wulfkuhle, Julia; Cardiff, Robert D.; Ambrose, Elizabeth A.; Georg, Gunda I.; Schwertfeger, Kaylee L.; Farrar, Michael A.; Croix, Brad St.; Goetz, Matthew P.; Potter, David A.
err分享
err收藏
Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation
err2023-03-27
err290
errOAAI
errGlading, A; Bodnar, RJ; Reynolds, IJ; Shiraha, H; Satish, L; Potter, DA; Blair, HC; Wells, A
err分享
err收藏
v-Src-induced modulation of the calpain-calpastatin proteolytic system regulates transformation
err2023-03-27
err106
errOAAI
errCarragher, NO; Westhoff, MA; Riley, D; Potter, DA; Dutt, P; Elce, JS; Greer, PA; Frame, MC
err分享
err收藏
Evaluation of Tucatinib plus (Paclitaxel plus Pertuzumab plus Trastuzumab) followed by AC in high-risk HER2 positive (HER2+) stage II/III breast cancer: Results from the I-SPY 2 TRIAL
err2022-02-15
err0
PREAI
errPotter, David A.; Roesch, Erin; Yau, Christina; Lu, Ruixiao; Wolf, Denise; Samson, Susan; Stafford, Debra; Albain, Kathy S.; Isaacs, Claudine; Trivedi, Meghana; Yee, Douglas; Boughey, Judy; Thomas, Alexandra; Chien, A. Jo; Hylton, Nola; Li, Wen; DeMichele, Angela; Perlmutter, Jane; Symmans, W. Fraser; Hershman, Dawn L.; Melisko, Michelle; Veer, Laura J. van ' t; Wilson, Amy; Asare, Smita M.; Berry, Donald A.; Schwab, Richard; Rugo, Hope S.; Esserman, Laura J.
err分享
err收藏
The 70-gene signature test as a prognostic and predictive biomarker in patients with invasive lobular breast cancer
err2021-10-29
err11
PREAI
errJenkins, J. Asher; Marmor, Schelomo; Hui, Jane Yuet Ching; Beckwith, Heather; Blaes, Anne H.; Potter, David; Tuttle, Todd M.
err分享
err收藏
Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor-Positive/HER2-Negative Advanced or Metastatic Breast Cancer
err2021-04-05
err9
errOAAI
errLim, Bora; Potter, David A.; Salkeni, Mohamad A.; Silverman, Paula; Haddad, Tufia C.; Forget, Frederic; Awada, Ahmad; Canon, Jean-Luc; Danso, Michael; Lortholary, Alain; Bourgeois, Hugues; Tan-Chiu, Elizabeth; Vincent, Sylvie; Bahamon, Brittany; Galinsky, Kevin J.; Patel, Chirag; Neuwirth, Rachel; Leonard, E. Jane; Diamond, Jennifer R.
err分享
err收藏
Metformin inhibits nuclear localization of estrogen receptor alpha in breast cancer cells, in part, by inhibition of CYP-mediated epoxyeicosatrienoic acid (EET) biosynthesis
err2020-08-15
err1
PREAI
errGuo, Zhijun; Lei, Jianxun; Wu, Shaoping; Molina-Vega, Julissa; Cervantes, Paloma; Rom'Mand, Aline R.; Mijangos, Dylan C. Castillejo; Falck, John R.; Lange, Carol; Wang, Jinhua; Potter, David A.
err分享
err收藏
Pathological complete response following neoadjuvant chemotherapy in operable breast cancer patients: Is obesity a predictive factor?
err2020-02-15
err0
PREAI
errWang, Haiyun; Zhang, Shijia; Yee, Douglas; Beckwith, Heather; Potter, David; Blaes, Anne
err分享
err收藏
Antiproliferative effects of type II diabetes agents in Fanconi derived oral squamous carcinoma
err2019-07-01
err0
PREAI
errMiller, Kim; Wuertz, Beverly; Potter, David; Ondrey, Frank G.
err分享
err收藏
CYP monooxygenases regulate nuclear localization of ERa and mTORC1 component RagC in ER+HER2-breast cancer cells
err2019-07-01
err0
PREAI
errGuo, Zhijun; Wu, Shaoping; Molina-Vega, Julissa; Castillo, Rafael; Barrera, Jaime; Johnson, Veronica; Lange, Carol; Potter, David
err分享
err收藏
Phase 2 safety and efficacy results of TAK-228 in combination with exemestane or fulvestrant in postmenopausal women with ERpositive/HER2-negative metastatic breast cancer previously treated with everolimus
err2019-02-15
err4
PREAI
errDiamond, J. R.; Potter, D.; Salkeni, M.; Silverman, P.; Haddad, T.; Forget, F.; Awada, A.; Canon, J-L; Danso, M.; Lortholary, A.; Bourgeois, H.; Tan-Chiu, E.; Patel, C.; Neuwirth, R.; Leonard, E. J.; Lim, B.
err分享
err收藏
A phase 1b study of poziotinib in combination with T-DM1 in women with advanced or metastatic HER2-positive breast cancer
err2019-02-15
err0
PREAI
errBhat, G.; Potter, D.; Bharadwaj, J.; Khan, N.; Shabazz, L.; Tache, J.; Yang, Z.
err分享
err收藏